Informed consent, participation in, and withdrawal from a population based cohort study involving genetic analysis
- 30 June 2005
- journal article
- Published by BMJ in Journal of Medical Ethics
- Vol. 31 (7) , 385-392
- https://doi.org/10.1136/jme.2004.009530
Abstract
Objective: Population based cohort studies involving genetic research have been initiated in several countries. However, research published to date provides little information on the willingness of the general population to participate in such studies. Furthermore, there is a need to discover the optimal methods for acquiring fully informed consent from the general population. We therefore examined the results of a population based genetic cohort study to identify the factors affecting the participation rate by members of the general public and also specifically to examine the impact of different consent procedures on the rate of participation by prospective candidates and their subsequent withdrawal rate from the study. Design: Descriptive analyses. Setting and participants: The study evaluated two non-genetic subcohorts comprising 3166 people attending for a health checkup during 2002, and two genetic subcohorts comprising 2195 people who underwent a checkup during 2003. Main outcome measurements: Analysis endpoints were differences in participation rates between the non-genetic and genetic subcohorts, differences between providing non-extensive and extensive preliminary information, and changes in participation status between baseline and at 6 months. Results: Participation rates in the genetic subcohorts were 4·7–9·3% lower than those in the non-genetic subcohorts. The odds ratios (OR) of participation in genetic research were between 0·60 and 0·77, and the OR for withdrawal from the research was over 7·70; providing preliminary extensive information about genetic research reduced the withdrawal risks (OR 0·15 for all dependent variables) but worsened participation rates (OR 0·63–0·74). Conclusions: The general population responded sceptically towards genetic research. It is crucial that genetic researchers utilise an informative and educational consent process worthy of public trust.Keywords
This publication has 18 references indexed in Scilit:
- The promise of human genetic databasesBMJ, 2001
- Predictors of participation in genetic research in a primary care physician network2000
- Safeguards for research using large scale DNA collectionsBMJ, 2000
- The Icelandic database---do modern times need modern sagas?BMJ, 1999
- Racial differences in testing motivation and psychological distress following pretest education for BRCA1 gene testing.1999
- Attitudes and interest in genetic testing for breast and ovarian cancer susceptibility in diverse groups of women in western Washington.1999
- Interest in Learning of Personal Genetic Risk for Cancer: A General Population SurveyPreventive Medicine, 1996
- The impact of disease severity on the informed consent process in clinical researchThe American Journal of Medicine, 1996
- Public Acceptance of Human Gene Therapy and Perceptions of Human Genetic ManipulationHuman Gene Therapy, 1992
- Informed Consent — Why Are Its Goals Imperfectly Realized?New England Journal of Medicine, 1980